{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:45:42Z","timestamp":1792453542861,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A04J4765"],"award-info":[{"award-number":["2025A04J4765"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515012533"],"award-info":[{"award-number":["2025A1515012533"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M744013"],"award-info":[{"award-number":["2023M744013"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372859"],"award-info":[{"award-number":["82372859"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403081"],"award-info":[{"award-number":["82403081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218381","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:58:34Z","timestamp":1772524714000},"page":"218381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cancer-associated fibroblasts drive gemcitabine resistance in pancreatic cancer by promoting ferroptosis resistance via the PAX6\/PAK3\/SLC3A2 axis"],"prefix":"10.1016","volume":"646","author":[{"given":"Huimou","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9902-8793","authenticated-orcid":false,"given":"Cao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3918-8903","authenticated-orcid":false,"given":"Honghui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218381_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218381_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218381_bib3","doi-asserted-by":"crossref","first-page":"12986","DOI":"10.1002\/cam4.5971","article-title":"Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med-Us"},{"key":"10.1016\/j.canlet.2026.218381_bib4","article-title":"nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial","volume":"107","author":"Goldstein","year":"2015","journal-title":"Jnci-J Natl Cancer I"},{"key":"10.1016\/j.canlet.2026.218381_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/COC.0b013e3182a46782","article-title":"Gemcitabine adjuvant therapy for resected pancreatic cancer: a meta-analysis","volume":"38","author":"Yu","year":"2015","journal-title":"Am J Clin Oncol-Canc"},{"key":"10.1016\/j.canlet.2026.218381_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218381_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103349","article-title":"UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling","volume":"76","author":"Song","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218381_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100960","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218381_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103200","article-title":"ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis","volume":"73","author":"Mao","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218381_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2019.04.026","article-title":"p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3beta-beta-catenin signaling pathway in pancreatic cancer cells","volume":"456","author":"Wu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218381_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/cas.12198","article-title":"Histological and prognostic importance of CD44(+)\/CD24(+)\/EpCAM(+) expression in clinical pancreatic cancer","volume":"104","author":"Ohara","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218381_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bcpt.13821","article-title":"The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: physiological and pathophysiological implications","volume":"133","author":"Kahlhofer","year":"2023","journal-title":"Basic Clin Pharmacol"},{"key":"10.1016\/j.canlet.2026.218381_bib13","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.7150\/thno.87968","article-title":"Metabolite Neu5Ac triggers SLC3A2 degradation promoting vascular endothelial ferroptosis and aggravates atherosclerosis progression in ApoE(-\/-)mice","volume":"13","author":"Xiang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218381_bib14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41418-023-01188-z","article-title":"Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma","volume":"30","author":"Ma","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218381_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","article-title":"Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity","volume":"6","author":"Zhou","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218381_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41556-025-01610-3","article-title":"PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer","volume":"27","author":"Fan","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218381_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-019-1591-4","article-title":"The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling","volume":"10","author":"Wu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218381_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","article-title":"Gemcitabine: a review of chemoresistance in pancreatic cancer","volume":"24","author":"Sarvepalli","year":"2019","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.canlet.2026.218381_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191422","article-title":"Targeting lactylation and the STAT3\/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma","volume":"135","author":"Chen","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218381_bib20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218381_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7150\/jca.61918","article-title":"PAK3 promotes the metastasis of hepatocellular carcinoma by regulating EMT process","volume":"13","author":"Gao","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2026.218381_bib22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s13402-021-00635-8","article-title":"PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth","volume":"44","author":"Magne","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2026.218381_bib23","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1038\/s41467-021-24898-9","article-title":"Loss of Smad4 promotes aggressive lung cancer metastasis by de-repression of PAK3 via miRNA regulation","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218381_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/scd.2017.0283","article-title":"PAX6 alternative splicing and corneal development","volume":"27","author":"Park","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.canlet.2026.218381_bib25","doi-asserted-by":"crossref","first-page":"33381","DOI":"10.1074\/jbc.M110.147215","article-title":"Pax6 controls the expression of critical genes involved in pancreatic alpha cell differentiation and function","volume":"285","author":"Gosmain","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218381_bib26","doi-asserted-by":"crossref","first-page":"27524","DOI":"10.1074\/jbc.M109.047209","article-title":"PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene","volume":"284","author":"Mascarenhas","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218381_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.503","article-title":"Oncogenic PAX6 elicits CDK4\/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218381_bib28","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-24-3180","article-title":"SLC3A2-Mediated lysine uptake by cancer cells restricts T-cell activity in hepatocellular carcinoma","volume":"85","author":"Chang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218381_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216732","article-title":"Acidosis activates breast cancer ferroptosis through ZFAND5\/SLC3A2 signaling axis and elicits M1 macrophage polarization","volume":"587","author":"Xiong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218381_bib30","article-title":"Design of hypoxia responsive CRISPR-Cas9 for target gene regulation","volume":"13","author":"An","year":"2023","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.canlet.2026.218381_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.omtm.2022.03.008","article-title":"Hypoxia-directed tumor targeting of CRISPR-Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles","volume":"25","author":"Davis","year":"2022","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.canlet.2026.218381_bib32","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7150\/thno.9404","article-title":"Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections","volume":"4","author":"Draz","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218381_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218381_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1251100","article-title":"CD98 heavy chain as a prognostic biomarker and target for cancer treatment","volume":"13","author":"Xia","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218381_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101981","article-title":"A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer","volume":"45","author":"Zheng","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218381_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002140","article-title":"Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2","volume":"9","author":"Pellizzari","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2026.218381_bib37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.gastro.2023.12.018","article-title":"Cancer-associated fibroblast induces acinar-to-ductal cell transdifferentiation and pancreatic cancer initiation via LAMA5\/ITGA4 axis","volume":"166","author":"Parte","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218381_bib38","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1080\/15548627.2023.2300913","article-title":"Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218381_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","article-title":"circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis","volume":"21","author":"Hu","year":"2022","journal-title":"Mol. Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:40:43Z","timestamp":1776858043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"alternative-id":["S0304383526001448"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218381","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated fibroblasts drive gemcitabine resistance in pancreatic cancer by promoting ferroptosis resistance via the PAX6\/PAK3\/SLC3A2 axis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218381"}}